AIM: (1) To evaluate the number of patients thrombolysed within 1 h of arrival to emergency room (ER) (2) To identify reasons for delay in thrombolysis of acute stroke patients. MATERIALS AND METHODS: All patients admitted to ER with symptoms suggestive of stroke from January 2011 to November 2013 were studied. Retrospective data were collected to evaluate ER to needle (door to needle time [DTNt]) time and reasons for delay in thrombolysis. The parameters studied (1) onset of symptoms to ER time, (2) ER to imaging time (door to imaging time [DTIt]), (4) ER to needle time (door to needle) and (5) contraindications for thrombolysis. RESULTS: A total of 695 patients with suspected stroke were admitted during study period. 547 (78%) patients were out of window period. 148 patients (21%, M = 104, F = 44) arrived within window period (<4.5 h.). 104 (70.27%) were contraindicated for thrombolysis. Majority were intracerebral bleeds. 44 (29.7%) were eligible for thrombolysis. 7 (15.9%) were thrombolysed within 1 h. The mean time for arrival of patients from onset of symptoms to hospital (symptom to door) 83 min (median - 47). The mean door to neuro-physician time (DTPt) was 32 min (median - 15 min). The mean DTIt was 58 min (median - 50 min). The mean DTNt 104 (median - 100 min). CONCLUSION: Reasons for delay in thrombolysis are: Absence of stroke education program for common people. Lack of priority for triage and imaging for stroke patients.
AIM: (1) To evaluate the number of patients thrombolysed within 1 h of arrival to emergency room (ER) (2) To identify reasons for delay in thrombolysis of acute strokepatients. MATERIALS AND METHODS: All patients admitted to ER with symptoms suggestive of stroke from January 2011 to November 2013 were studied. Retrospective data were collected to evaluate ER to needle (door to needle time [DTNt]) time and reasons for delay in thrombolysis. The parameters studied (1) onset of symptoms to ER time, (2) ER to imaging time (door to imaging time [DTIt]), (4) ER to needle time (door to needle) and (5) contraindications for thrombolysis. RESULTS: A total of 695 patients with suspected stroke were admitted during study period. 547 (78%) patients were out of window period. 148 patients (21%, M = 104, F = 44) arrived within window period (<4.5 h.). 104 (70.27%) were contraindicated for thrombolysis. Majority were intracerebral bleeds. 44 (29.7%) were eligible for thrombolysis. 7 (15.9%) were thrombolysed within 1 h. The mean time for arrival of patients from onset of symptoms to hospital (symptom to door) 83 min (median - 47). The mean door to neuro-physician time (DTPt) was 32 min (median - 15 min). The mean DTIt was 58 min (median - 50 min). The mean DTNt 104 (median - 100 min). CONCLUSION: Reasons for delay in thrombolysis are: Absence of stroke education program for common people. Lack of priority for triage and imaging for strokepatients.
Entities:
Keywords:
Acute ischemic stroke; thrombolysis triage and stroke code team; window period
Thrombolysis with recombinant tissue plasminogen activator (rtPA, alteplase) is the only effective specific treatment for acute ischemic strokepatients coming in window (4.5 h from onset of symptoms).[1] A milestone study of National Institute of Neurological Disorders and Stroke in 1995, demonstrated the benefits of rtPA in to patients of acute ischemic stroke (AIS) who came within window period. These patients of AIS who were thrombolysed were 30% more likely to survive with minimal disability resulting in a 12% absolute increase in the proportion having excellent functional outcomes at 3 months.[2] After publication of the European Cooperative Acute. Stroke Study III trail (2008) window period was extended to 4.5 h. For every 15 min reduction in door to needle time (DTNt) there is 5% reduction in odds of in hospital mortality (odd ratio, 0.95; 95% confidence interval, 0.92-0.98: P = 0.0007).[3]
Materials and Methods
This is retrospective study which was approved by Institutional ethical board committee. All patients who presented with stroke to emergency department (ER) from January 2011 to December 2013 were included in the study. After initial assessment by causality personnel a medical/neuro-resident evaluated the patient. Radiological diagnosis was obtained with noncontrasted brain computed tomography and/or diffusion weighted magnetic resonance imaging (DWI). Images were evaluated by a radiologist. After neuro physician opinion or after telephonic discussion by neuro-resident with neuro physician (telestroke) the treatment plan was decided. For the patients who presented within window period thrombolysis was planned. Severity of Stroke was documented by The National Institutes of Health Stroke Scale (NIHSS). Risk factor for stroke were recorded. Contra-indications for thrombolysis were checked and consent of relatives/patient was taken. Those patients who presented out of window period (>4.5 h after onset of symptom/symptom to door time [STD] >4.5 h), or patients who had hemorrhagic stroke and those who were not willing for giving consent were excluded [Figure 1].
Figure 1
Algorithm for patient presenting with stroke in emergency room (protocol used in the study)
Algorithm for patient presenting with stroke in emergency room (protocol used in the study)Patients record files and charts were used to extract retrospective data. The collected data use to evaluate ER to needle [door to needle time-(DTNt)] time and reasons for delay in thrombolysis therapy in acute strokepatients.The following parameters were studiedOnset of symptoms to ER time,Assessment by physician/medical chief resident time (door to physician time [DTPt])ER to imaging time (door to imaging time [DTIt]),ER to needle time (DTNt)Contraindications for thrombolysis.The onset of symptom time for patients with wake up was accepted as last time the patient was seen as healthy.The baseline characteristics of patient with acute ischemic stroke brought/admitted to ER, clinical features, arrival time (door time) to ER, severity of stroke, imaging time, radiological findings, contraindication for thrombolytic treatment, time of starting recombinant tissue plasminogen activator (rt-PA) and thereafter complications were recorded [Table 2].
Table 2
Baseline clinical characteristics of thrombolysed patients (n=44)
The data abstracted were transferred to the SPSS™ 17.0 program (SPSS statistics is a software package used for statistical analysis. It is Statistical Package for Social Science and is produced by SPSS Inc.) of the computer for statistical analysis. The data were summarized as mean ± standard deviation, median and percentages.
Results
Six hundred and ninety-five patients with symptoms of stroke were presented to our emergency department in the study period. Out of these five hundred and forty seven (78.7%) were excluded as they had come out of window period that is, they had arrived 4.5 h after the onset of stroke symptoms. Thus, only 148 patients were included (21.2%) [Figure 1]. Algorithm for patient presenting with stroke in ER (protocol used in the study).Further after imaging of these one hundred and forty eight patients, one hundred four (70.27%) were excluded. Sixty-two (59.6%) had intra cerebral bleed, 1 (0.9%) had hemoglobin - 3.1 g, 13 (13%) of them had transient ischemic attack (neurological symptoms improved) and DWI images of these patient were normal. Relatives of 6 (5.7%) patients refused to give consent for thrombolysis. 6 (5.7) patients were diagnosed to have metabolic de-rrangement (hypoglycemia, hyperglycemia, hyponatremia).Three (2.8%) patients had large middle cerebral artery infarct (MCA). Two (1.9%) patients had acute ischemic attack secondary to mastoiditis. One (0.9%) patients denied to undergo thrombolysis. Three (2.8%) patients had recent stroke history. Other reasons for exclusion in our study were post-ictal status, financial problem, recent thrombolysis, recent surgery, and delay in contacting senior radiologist [Table 1].
Table 1
Distribution of contraindications for thrombolytic therapy of patients
Distribution of contraindications for thrombolytic therapy of patientsBaseline clinical characteristics of thrombolysed patients (n=44)Total 44 (29.7%) patients with AIS were thrombolysed. Thirty-four (79.5%) were male and nine (20.45%) were female. Mean age of our patients was 57.32 years ranging from 24 to 79. Co-morbid illness in the form of hypertension 6 (13.6%), diabetes 2 (4.5%), ischemic heart diseases (IHD) 2 (4.5%), previous stroke CVA 3 (6.5%), >1 co-morbidity (HT/CVA/DM/IHD/Hypothyriod) 19 (43%), seizure 1 (2%) and alcoholic liver diseases 1 (2%) patients respectively. 1414 (31%) patients had no co-morbidity [Table 2].The mean blood pressure at admission was 140/90 mmHg. 11 (25%) of them required labetalol before treatment. The baseline NIHSS score was 9.95 (2-21). The mean time for arrival of patients from onset of symptoms to hospital (STD) 1.23 h (15 min-3 h). The mean door to neuro-physician time DTPt was 32 min (5 min-2.23 h). The mean DTIt, DTIt was 58 min (5 min-4 h). The mean DTNt 1.44 h (40 min-3.3 h) [Tables 3 and 4], [Figures 2–4].
Table 3
Our study DTPt, DTIt and DTNt compared with AHA guideline interval
Table 4
Number of patients thrombolysed per hour
Figure 2
Door to physician time
Figure 4
Door to needle time
Our study DTPt, DTIt and DTNt compared with AHA guideline intervalNumber of patients thrombolysed per hourDoor to physician timeDoor to imaging time (recommended standard time: ≤ 45 min)Door to needle time
Discussion
“Earlier the better” is stated in our guidelines.[8] Analysis of our study clearly states that STDt, DTPt, DTIt, and DTNt time are significantly more. Thus, we had many hurdles in delivering thrombolysis therapy to these 44 patients. Only 7 (15%) patients had DTNt ≤ 60 min. Fonarrow et al. study showed only 26.6% of patients had DTNt of recommended period <60 min.[3]The problems/barriers in our study were categorized into three factors:
Pre-hospital
Mean symptom to door time was 83 min (median: 69). Lack of awareness of stroke symptoms in our community was main cause in delay.Inaccessiblity to emergency medical services have contributed to delay. Poor recognition of stroke signs, especially in older patients caused delay in arrival time to hospital.[2] Public and emergency medical services staff education play important role in shortening the pre hospital period.[4]
Hospital factors
In our study-door to physician, door to imaging and door to needle time were significantly ore compared to standard recommendations (AHA) [Table 3].There was lack of handling strokepatients with high priority at each level ER, imaging unit, stroke unit. Thus lack of triaging strokepatient at all level of intervention was our weakest point. There was delay in informing reference to neuro physician in two of our patients. Education of emergency medical services of stroke symptoms will help to triage strokepatient.[5] In one of the patients the on call doctor was very busy attending emergency calls so causing increase in DTPt time. The concept of having second on call doctor who takes care only of patients with acute stroke has being recommended by Kobayashi et al.[2]Lack of triaging at radiology unit and performing entire sequences of magnetic resonance imaging (MRI) scan lead to increase in DTIt. Thus again prioritizing the strokepatient at radiology unit will help us to improvise.[6] Another important point is to perform only DWI image for deciding the thrombolysis therapy.[7] DWI has high sensitivity (88-100%) and specificity (95-100%) for detecting infarcted regions, within minutes of onset of symptoms.[8] Stephanie Paolini et al. study suggested “brain attack team MRI sequence” of <10 min to confirm acute ischemia stroke and assess candidacy for IV-rtPA.[10] Lack of triaging of bed for strokepatients resulted in increase in DTNt time. To prevent these delay we started thrombolysing AIS patient in ER. To prevent delay due to inavailability of drug, we have started keeping rtPA in our drug stock
Patient factors
Our DTNt was 104 min (door to needle time median - 100).Patient with raised blood pressure requiring labetalol infusion caused delay. Relatives with geriatric patient (79 years) took longer time to give consent due to age of the patient and secondly due to financial burden. One of our patients had liver diseases so we had to wait for international normal ratio report for prothrombin time (international normalized ratio). One of our patients was in post-ictal state causing delay in thrombolysis. Recent guidelines removes this controversy if DWI images are done. In 2011 and 2012 transient ischemic attack patients were not thrombolysed, but in latter half of study DWI images helped us to prevent delay.
Conclusions
The barriers of thrombolysis in our study included:Lack of public awareness and Inaccessiblity to emergency medical servicesLack of prioritizing triage system at ER, radiology unit and stroke unitLack of a multi-disciplinary stroke care team.[58]A multi-disciplinary stroke care team consists of well-established emergency medical services, physicians, neurologist, nurses, radiology staff, neuro-radiologist, and pharmacist. Forming a one-call comprehensive “stroke code” will help in co-ordination at all level. Time to time audit of quality indicator of stroke code team may help to overcome the factors for delay in DTNt.
Authors: Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm Journal: Circulation Date: 2011-02-10 Impact factor: 29.690
Authors: Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas Journal: Stroke Date: 2013-01-31 Impact factor: 7.914
Authors: Rosalind F Yu; Maria Cristina Z San Jose; Brenda M Manzanilla; Michael Y Oris; Robert Gan Journal: J Neurol Sci Date: 2002-07-15 Impact factor: 3.181
Authors: Oscar Salvador Barrera-Vázquez; Juan Carlos Gomez-Verjan; Ricardo Ramírez-Aldana; Paola García-Dela Torre; Nadia Alejandra Rivero-Segura Journal: Int J Mol Sci Date: 2022-04-23 Impact factor: 6.208
Authors: Sushma K Gurav; Kapil G Zirpe; R S Wadia; Avinash Naniwadekar; Prajakta U Pote; Amit Tungenwar; Abhijeet M Deshmukh; Srikanta Mohopatra; Balakrishna Nimavat; Prasad Surywanshi Journal: Indian J Crit Care Med Date: 2018-04